Quantitative 18F-FDG PET-CT can assess presence and extent of interstitial lung disease in early severe diffuse cutaneous systemic sclerosis
Open Access
- 19 December 2024
- journal article
- research article
- Published by Springer Nature in Arthritis Research & Therapy
- Vol. 26 (1) , 1-9
Abstract
Background: This study aimed to assess the quantitative uptake of 18F-FDG PET-CT in the lungs of patients with early severe diffuse cutaneous systemic sclerosis (SSc) with and without interstitial lung disease (ILD), compared to controls. In patients with SSc-ILD, 18F-FDG uptake was correlated to high-resolution computed tomography (HRCT) and pulmonary function test (PFT) parameters. Methods: A prospective, cross-sectional study was conducted, involving 15 patients with SSc-ILD, 5 patients with SSc without ILD, and 7 controls without SSc. 18F-FDG PET-CT scans were performed following standardized protocols, and quantitative analysis of tracer uptake was conducted in predefined lung regions. In addition, HRCT scans were evaluated for ILD-related radiologic abnormalities. Between-group differences were compared with non-parametric tests, while correlations with PFT parameters were analyzed using Spearman correlation coefficients. Results: 18F-FDG uptake was mainly increased in the dorsobasal lung fields of patients with SSc-ILD compared to SSc without ILD and controls (p = 0.03 and p < 0.001, respectively). 18F-FDG uptake was higher in SSc patients with extensive ILD (≥ 20% vs < 20%, p = 0.04) and correlated with lower DLCO% (R = -0.59, p = 0.02). Ground-glass opacities, with or without reticulation, corresponded to increased 18F-FDG uptake. Conclusions: 18F-FDG PET-CT can detect metabolic activity in the lungs of patients with early severe diffuse cutaneous SSc and ILD, correlating with higher ILD extent (≥ 20%) and lower DLCO%. These results suggest the potential utility of 18F-FDG PET-CT in the early detection of ILD (progression) and aiding in risk stratification.Keywords
Funding Information
- Dutch Arthritis Society
- ZonMw
- Boehringer Ingelheim
This publication has 44 references indexed in Scilit:
- Pharmacological treatments for SSc-ILD: Systematic review and critical appraisal of the evidenceAutoimmunity Reviews, 2021
- Clinical quantification of the integrin αvβ6 by [18F]FB-A20FMDV2 positron emission tomography in healthy and fibrotic human lung (PETAL Study)European Journal of Nuclear Medicine and Molecular Imaging, 2019
- Predictors of morbidity and mortality in early systemic sclerosis: Long-term follow-up data from a single-centre inception cohortAutoimmunity Reviews, 2018
- Short‐Term Pulmonary Function Trends Are Predictive of Mortality in Interstitial Lung Disease Associated With Systemic SclerosisArthritis & Rheumatology, 2017
- FDG-PET/CT in the prediction of pulmonary function improvement in nonspecific interstitial pneumonia. A Pilot StudyEuropean Journal of Radiology, 2016
- Predictive Value of Serial High‐Resolution Computed Tomography Analyses and Concurrent Lung Function Tests in Systemic SclerosisArthritis & Rheumatology, 2015
- FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0European Journal of Nuclear Medicine and Molecular Imaging, 2014
- Role of FDG-PET and PET/CT in the diagnosis and management of vasculitisEuropean Journal of Radiology, 2010
- 18FDG uptake associated with CT density on PET/CT in lungs with and without chronic interstitial lung diseasesAnnals of Nuclear Medicine, 2009
- Positron Emission Tomography2005